HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People On The Move: Appointments At Nestlé, Sanofi, Fimea

Executive Summary

A round-up of the latest appointments in Europe's health and wellness markets: Nestlé Health Science promotes Anna Mohl to CEO; Sanofi Consumer Healthcare names Thomas Bosment Romania country head; Fimea reappoints Eija Pelkonen as director general for another five year term.

You may also be interested in...



Nestlé Hit By US Supply Chain Issue Expected To Impact VMS Sales Into 2024

Nestlé insists it is “on top of” an unexpected supply chain problem which emerged in the US in August and has since hit sales of its dietary supplements in North America. The company revealed the issue as it reported flat sales at its Health Science business for the opening nine months of 2023.

US Health And Wellness Executive Decisions: Perrigo, Nestle, Flexpower Health, Herbalife, More

NBA star Antetokounmpo invests in Flexpower; Perrigo changes Americas helm; Bündchen models healthy lifestyle for Gaia; Vit-Best appoints growth chief; Olympian Jennings works with Protein Puck; and more.

People On The Move: Appointments At Norgine, Lonza, Sabinsa

A round-up of the latest appointments in Europe's health and wellness markets: Norgine names former L'Oreal exec as COO; Lonza appoints chairman to interim-CEO role; and Sabinsa hires head for new French office.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154066

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel